MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$176,684K
Free Cash flow
$549,451K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from sale of short-term...
Stock-based compensation expense
Accounts payable
Others
Negative Cash Flow Breakdown
Repayment of 0 percent convertib...
Purchases of short-term investme...
Other current and long-term asse...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Net loss
-114,646
59,465
-128,606
-23,387
Depreciation
3,433
-3,448
2,255
4,494
Amortization of right-of-use operating lease assets
3,505
-3,318
1,626
5,177
Amortization of other assets
700
-1,140
621
1,180
Amortization of discount on investments, net
3,343
-11,873
5,085
12,978
Amortization of debt issuance costs
1,801
-2,591
1,652
3,288
Non-cash royalty revenue related to sale of royalties
10,698
-26,789
13,584
24,894
Non-cash interest related to sale of future royalties
17,354
-37,780
17,799
37,165
Stock-based compensation expense
45,595
-47,279
31,146
59,408
Loss (gain) on investments, net
-10,182
13,146
29,908
-20,471
Non-cash losses related to other assets
441
3,683
-3,940
297
Escrow deposit for maturity of 0 percent convertible senior notes due april 2026
-
632,511
-
-
Contracts receivable
-14,839
75,205
-27,972
-39,608
Inventories
24,964
-14,938
2,135
12,465
Other current and long-term assets
30,875
-116,099
100,953
22,536
Accounts payable
21,678
26,021
-8,807
-20,309
Income taxes
3
94
20
47
Accrued compensation
14,244
-67,592
10,455
-23,050
Accrued liabilities and other liabilities
-8,152
-66,680
84,148
3,535
Deferred contract revenue
-8,077
29,783
-16,113
-34,488
Net cash provided by (used in) operating activities
565,531
-661,945
-131,437
563
Purchases of short-term investments
320,250
-933,840
323,938
802,657
Proceeds from sale of short-term investments
361,981
-549,927
422,206
880,545
Purchases of property, plant and equipment
16,080
-8,389
5,270
24,882
Acquisition of licenses and other assets, net
2,154
-2,789
1,660
2,615
Net cash provided by investing activities
23,497
395,091
91,338
50,391
Proceeds from issuance of common stock through equity plans, net
20,258
-27,485
81,259
3,528
Proceeds from issuance of common stock in public offering, net
-
-
0
-
Repayment of 0 percent convertible senior notes due 2026
432,511
-
-
-
Principal payments on mortgage debt
41
-79
41
82
Net cash provided by (used in) financing activities
-412,294
-27,406
81,218
3,446
Effects of exchange rates on cash
-50
-883
-82
827
Net increase (decrease) in cash and cash equivalents
176,684
-295,143
41,037
55,227
Cash and cash equivalents at beginning of period
338,341
338,341
242,077
-
Cash and cash equivalents at end of period
350,065
173,381
338,341
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
something is missing
$632,511K
Proceeds from sale of
short-term investments
$361,981K
(-58.89%↓ Y/Y)
Stock-based compensation
expense
$45,595K
(-23.25%↓ Y/Y)
Accounts payable
$21,678K
(206.74%↑ Y/Y)
Non-cash interest
related to sale of future...
$17,354K
(-53.31%↓ Y/Y)
Contracts receivable
-$14,839K
(62.54%↑ Y/Y)
Accrued compensation
$14,244K
(161.80%↑ Y/Y)
Loss (gain) on
investments, net
-$10,182K
(50.26%↑ Y/Y)
Amortization of right-of-use
operating lease assets
$3,505K
(-32.30%↓ Y/Y)
Depreciation
$3,433K
(-23.61%↓ Y/Y)
Amortization of debt issuance
costs
$1,801K
(-45.23%↓ Y/Y)
Amortization of other assets
$700K
(-40.68%↓ Y/Y)
Non-cash losses related
to other assets
$441K
(48.48%↑ Y/Y)
Income taxes
$3K
(-93.62%↓ Y/Y)
Net cash provided by
(used in) operating...
$565,531K
(100349.56%↑ Y/Y)
Net cash provided by
investing activities
$23,497K
(-53.37%↓ Y/Y)
Canceled cashflow
$200,755K
Canceled cashflow
$338,484K
Net increase
(decrease) in cash and cash...
$176,684K
(219.92%↑ Y/Y)
Canceled cashflow
$412,344K
Net loss
-$114,646K
(-390.21%↓ Y/Y)
Other current and
long-term assets
$30,875K
(37.00%↑ Y/Y)
Inventories
$24,964K
(100.27%↑ Y/Y)
Non-cash royalty revenue
related to sale of...
$10,698K
(-57.03%↓ Y/Y)
Accrued liabilities and
other liabilities
-$8,152K
(-330.61%↓ Y/Y)
Deferred contract
revenue
-$8,077K
(76.58%↑ Y/Y)
Amortization of discount on
investments, net
$3,343K
(-74.24%↓ Y/Y)
Proceeds from issuance of
common stock through...
$20,258K
(474.21%↑ Y/Y)
Purchases of short-term
investments
$320,250K
(-60.10%↓ Y/Y)
Purchases of property,
plant and equipment
$16,080K
(-35.37%↓ Y/Y)
Acquisition of licenses and
other assets, net
$2,154K
(-17.63%↓ Y/Y)
Net cash provided by
(used in) financing...
-$412,294K
(-12064.42%↓ Y/Y)
Effects of exchange
rates on cash
-$50K
(-106.05%↓ Y/Y)
Canceled cashflow
$20,258K
Repayment of 0 percent
convertible senior notes due...
$432,511K
Principal payments on
mortgage debt
$41K
(-50.00%↓ Y/Y)
Buy us a coffee
IONIS PHARMACEUTICALS INC (IONS)
IONIS PHARMACEUTICALS INC (IONS)